Clariane SE risk profile

47 Elevated one input has moved against it

Measured 21 October 2026 from CLARI's filed statements. Recomputed nightly.

47 (Elevated), driven by Leverage and coverage at 73, over 6 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation47ElevatedStableOne-year price volatility — 36.8%
Operating pressure43ElevatedStableCosts outgrowing revenue — +0.1 percentage points
Cash conversion12ContainedEasingCapital spending against operating cash — 0.24x
Leverage and coverage73StretchedEasingNet debt to EBITDA — 6.09x
Competitive position56ElevatedStableRevenue-growth gap against peers — -16.4 percentage points
Concentration37NormalStableGeographic concentration — 2,846 HHI

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for Clariane SE